应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01167 加科思-B
午间休市 04-16 12:05:00
8.170
+0.170
+2.13%
最高
8.260
最低
8.000
成交量
311.97万
今开
8.100
昨收
8.000
日振幅
3.25%
总市值
64.22亿
流通市值
64.22亿
总股本
7.86亿
成交额
2,531万
换手率
0.40%
流通股本
7.86亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
加科思-B回购6.63万股股份,总额约46.72万港元
公告速递 · 04-13 18:36
加科思-B回购6.63万股股份,总额约46.72万港元
加科思-B于4月10日斥资49.45万港元回购6.84万股
新浪港股 · 04-13
加科思-B于4月10日斥资49.45万港元回购6.84万股
加科思-B:4月10日回购6.84万股,耗资约49.45万港元
公告速递 · 04-10
加科思-B:4月10日回购6.84万股,耗资约49.45万港元
加科思-B(01167)4月10日斥资49.45万港元回购6.84万股
智通财经 · 04-10
加科思-B(01167)4月10日斥资49.45万港元回购6.84万股
加科思-B更新2026年3月股份变动月报表,股本总数保持不变
公告速递 · 04-09
加科思-B更新2026年3月股份变动月报表,股本总数保持不变
加科思-B(01167)4月8日耗资约49.44万港元回购6.84万股
智通财经 · 04-08
加科思-B(01167)4月8日耗资约49.44万港元回购6.84万股
加科思-B 4月8日回购6.84万股股份,耗资约49.44万港元
公告速递 · 04-08
加科思-B 4月8日回购6.84万股股份,耗资约49.44万港元
加科思-B:4月2日回购6.93万股,耗资约49.76万港元
公告速递 · 04-02
加科思-B:4月2日回购6.93万股,耗资约49.76万港元
加科思-B(01167)4月2日斥资49.76万港元回购6.93万股
智通财经 · 04-02
加科思-B(01167)4月2日斥资49.76万港元回购6.93万股
加科思-B回购3.60万股股份,总额约24.97万港元
公告速递 · 03-31
加科思-B回购3.60万股股份,总额约24.97万港元
加科思-B(01167)3月31日斥资24.97万港元回购3.6万股
智通财经 · 03-31
加科思-B(01167)3月31日斥资24.97万港元回购3.6万股
加科思-B(01167)收到阿斯利康就泛KRAS抑制剂JAB-23E73订立的许可及合作协议项下的1亿美元首付款
智通财经 · 03-30
加科思-B(01167)收到阿斯利康就泛KRAS抑制剂JAB-23E73订立的许可及合作协议项下的1亿美元首付款
加科思-B(01167)3月23日斥资49.98万港元回购8.01万股
智通财经 · 03-23
加科思-B(01167)3月23日斥资49.98万港元回购8.01万股
加科思-B:3月23日回购8.01万股,耗资约49.98万港元
公告速递 · 03-23
加科思-B:3月23日回购8.01万股,耗资约49.98万港元
加科思-B(01167)3月20日斥资50.92万港元回购7.62万股
智通财经 · 03-20
加科思-B(01167)3月20日斥资50.92万港元回购7.62万股
加科思-B:3月20日回购7.62万股股份,耗资约50.92万港元
公告速递 · 03-20
加科思-B:3月20日回购7.62万股股份,耗资约50.92万港元
加科思-B(01167)回购15万股股份,总额约101.3万港元
公告速递 · 03-19
加科思-B(01167)回购15万股股份,总额约101.3万港元
加科思-B(01167)回购14.4万股股份,总额约99.8万港元
公告速递 · 03-18
加科思-B(01167)回购14.4万股股份,总额约99.8万港元
加科思-B(01167)3月18日斥资99.8万港元回购14.4万股
智通财经 · 03-18
加科思-B(01167)3月18日斥资99.8万港元回购14.4万股
加科思-B(01167)回购144,000股股份,涉资约100.49万港元
公告速递 · 03-17
加科思-B(01167)回购144,000股股份,涉资约100.49万港元
加载更多
公司概况
公司名称:
加科思-B
所属市场:
SEHK
上市日期:
--
主营业务:
加科思药业集团有限公司是一家主要从事临床阶段新药研发的投资控股公司。该公司主要负责创新肿瘤疗法的自主发现和开发。该公司主要药物开发项目包括JAB-21822及JAB-3312临床阶段的变构SHP2抑制剂。该公司主要在中国市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01167","market":"HK","secType":"STK","nameCN":"加科思-B","latestPrice":8.17,"timestamp":1776312300002,"preClose":8,"halted":0,"volume":3119700,"delay":0,"changeRate":0.02124999999999999,"floatShares":786000000,"shares":786000000,"eps":-0.2165653893396404,"marketStatus":"午间休市","change":0.17,"latestTime":"04-16 12:05:00","open":8.1,"high":8.26,"low":8,"amount":25314534,"amplitude":0.0325,"askPrice":8.18,"askSize":4500,"bidPrice":8.16,"bidSize":900,"shortable":3,"etf":0,"ttmEps":-0.2165653893396404,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776315600000},"marketStatusCode":3,"adr":0,"listingDate":1608480000000,"exchange":"SEHK","adjPreClose":8,"openAndCloseTimeList":[[1776303000000,1776312000000],[1776315600000,1776326400000]],"volumeRatio":1.505294,"lotSize":300,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01167","defaultTab":"news","newsList":[{"id":"1168101812","title":"加科思-B回购6.63万股股份,总额约46.72万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168101812","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168101812?lang=zh_cn&edition=full","pubTime":"2026-04-13 18:36","pubTimestamp":1776076569,"startTime":"0","endTime":"0","summary":"加科思-B(股票代码:01167)于2026年4月13日发布翌日报表显示,该公司于同日在香港联交所场内回购普通股66,300股,占当日公司已发行股本约0.0084%,回购价格介乎每股7.04港元至7.05港元,总金额约46.72万港元。回购后,公司已发行股份总数保持在791,755,080股,其中785,731,080股为流通股,库藏股增加至6,024,000股。\n根据公告,购回授权于2025年6月10日获股东批准,剩余可回购股份数目为78,873,528股。公司确认本次交易符合香港联交所证券上市规则及相关法律程序的要求。公告由董事王晓洁签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627102359","title":"加科思-B于4月10日斥资49.45万港元回购6.84万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627102359","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627102359?lang=zh_cn&edition=full","pubTime":"2026-04-13 08:16","pubTimestamp":1776039360,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 加科思-B(01167)发布公告,于2026年4月10日斥资49.45万港元回购6.84万股。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-04-13/doc-inhuiatq4960518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","01167","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169920322","title":"加科思-B:4月10日回购6.84万股,耗资约49.45万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169920322","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169920322?lang=zh_cn&edition=full","pubTime":"2026-04-10 23:00","pubTimestamp":1775833247,"startTime":"0","endTime":"0","summary":"加科思-B(01167)于2026年4月10日公告,确认在香港联交所场内回购68,400股普通股,占当日已发行股本约0.0087%。此次回购每股价格介乎7.20港元至7.25港元,总计耗资494,526港元(约49.45万港元)。\n公告显示,回购完成后,公司已发行股本变动为785,797,380股,库藏股数增至5,957,700股。根据此前由股东在2025年6月10日通过的购回授权,公司可回购最多78,873,528股。截至本次回购累计已回购2,937,900股,占购回授权时已发行股本约0.37248%。\n公司指出,此次回购遵循香港联交所上市规则及相关法规。公告由董事王晓洁签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626811609","title":"加科思-B(01167)4月10日斥资49.45万港元回购6.84万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2626811609","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626811609?lang=zh_cn&edition=full","pubTime":"2026-04-10 22:59","pubTimestamp":1775833175,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)发布公告,于2026年4月10日斥资49.45万港元回购6.84万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427381.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154197189","title":"加科思-B更新2026年3月股份变动月报表,股本总数保持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1154197189","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154197189?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:42","pubTimestamp":1775724173,"startTime":"0","endTime":"0","summary":"加科思药业集团有限公司于2026年4月9日公布2026年3月股份变动月报表,报告期为2026年3月1日至3月31日。于本月末,公司已发行股份总数仍为791,755,080股,其中非库存股份为786,003,480股,库存股份为5,751,600股。上述已发行股份与上月底持平,但非库存股份较上月底减少669,300股,库存股份则相应增加669,300股。公告显示,公司在2026年3月16日至3月31日期间,于市场购回普遍股合计669,300股,购回价格区间为每股HKD 6.24至HKD 7.03,购回股份均以库存方式持有。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625943028","title":"加科思-B(01167)4月8日耗资约49.44万港元回购6.84万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2625943028","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625943028?lang=zh_cn&edition=full","pubTime":"2026-04-08 19:22","pubTimestamp":1775647363,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)公布,2026年4月8日耗资约49.44万港元回购6.84万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426128.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01167","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114994111","title":"加科思-B 4月8日回购6.84万股股份,耗资约49.44万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114994111","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114994111?lang=zh_cn&edition=full","pubTime":"2026-04-08 19:21","pubTimestamp":1775647288,"startTime":"0","endTime":"0","summary":"加科思药业集团有限公司于2026年4月8日发布翌日披露报表,宣布在香港联交所场内回购股份。本次回购共涉及68,400股,约占公司现有已发行股本的0.0087%。回购价格介乎每股7.21港元至7.27港元,支付总金额494,445港元,折合约49.44万港元。回购完成后,公司已发行股本变动至785,865,780股,库藏股数增加至5,889,300股。公司购回授权于2025年6月10日获股东大会通过,可回购总数为78,873,528股,截至目前已回购2,869,500股。上述公告由公司董事王晓洁签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127832941","title":"加科思-B:4月2日回购6.93万股,耗资约49.76万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127832941","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127832941?lang=zh_cn&edition=full","pubTime":"2026-04-02 18:26","pubTimestamp":1775125581,"startTime":"0","endTime":"0","summary":"加科思-B(01167)于2026年4月2日公告,已在香港联交所场内回购股份。根据公告,公司当日共购回69,300股普通股,占已发行股本约0.00882%,每股回购价介乎港币7.17元至7.20元,合计支付约49.76万港元。\n回购完成后,公司已发行股本减少至785,934,180股,同时库藏股数增至5,820,900股。公司此前于2025年6月10日通过购回授权,可供回购的总数为78,873,528股,截至目前累计购回2,801,100股。\n公司确认已遵守香港联交所相关上市规则及适用法例。公告由董事王晓洁签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624957027","title":"加科思-B(01167)4月2日斥资49.76万港元回购6.93万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624957027","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624957027?lang=zh_cn&edition=full","pubTime":"2026-04-02 18:24","pubTimestamp":1775125459,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)发布公告,于2026年4月2日该公司斥资49.76万港元回购6.93万股,回购价格为每股7.17-7.20港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01167","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110394815","title":"加科思-B回购3.60万股股份,总额约24.97万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1110394815","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110394815?lang=zh_cn&edition=full","pubTime":"2026-03-31 18:31","pubTimestamp":1774953097,"startTime":"0","endTime":"0","summary":"加科思-B(股票代码:01167)于2026年3月31日发布公告,披露公司当日在香港联交所场内回购股份36,000股,占已发行股本约0.00458%。本次回购每股价格介乎6.92港元至6.95港元,总涉资约24.97万港元。\n回购完成后,公司已发行股本变动为786,003,480股,库藏股数量增至5,751,600股。此次回购基于2025年6月10日获得的购回授权,该授权可回购78,873,528股股份,截至公告日累计已回购2,731,800股,占获授权时已发行股本约0.34635%。\n公司确认,回购事宜遵守香港联交所证券上市规则及相关法例。公告由董事王晓洁签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623375588","title":"加科思-B(01167)3月31日斥资24.97万港元回购3.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623375588","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623375588?lang=zh_cn&edition=full","pubTime":"2026-03-31 18:30","pubTimestamp":1774953045,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)发布公告,于2026年3月31日,该公司斥资24.97万港元回购3.6万股股份,每股回购价6.92-6.95港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423074.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01167","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623369335","title":"加科思-B(01167)收到阿斯利康就泛KRAS抑制剂JAB-23E73订立的许可及合作协议项下的1亿美元首付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2623369335","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623369335?lang=zh_cn&edition=full","pubTime":"2026-03-30 08:02","pubTimestamp":1774828968,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)发布公告,内容有关北京加科思新药研发有限公司(北京加科思,本集团的非全资附属公司)与AstraZeneca AB(阿斯利康)订立了许可与合作协议。本公司的附属公司北京加科思就其订立的许可及合作协议,已收到阿斯利康支付的1亿美元的首付款。该首付款的到账,进一步充盈了本集团的现金储备,也将为本集团后续创新肿瘤疗法管线研发的推进提供助力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421428.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0889565916.HKD","AZN","BK1161","BK4588","IE00B3T34201.USD","LU0289739699.SGD","LU0109394709.USD","BK4568","BK4585","LU0058720904.USD","LU2417539215.USD","LU1829250122.USD","BK4007","LU0320765992.SGD","LU2236285917.USD","LU2456880835.USD","BK1574","01167","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621774010","title":"加科思-B(01167)3月23日斥资49.98万港元回购8.01万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621774010","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621774010?lang=zh_cn&edition=full","pubTime":"2026-03-23 18:14","pubTimestamp":1774260862,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)发布公告,于2026年3月23日,该公司斥资49.98万港元回购8.01万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417454.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01167","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174070223","title":"加科思-B:3月23日回购8.01万股,耗资约49.98万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1174070223","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174070223?lang=zh_cn&edition=full","pubTime":"2026-03-23 18:01","pubTimestamp":1774260111,"startTime":"0","endTime":"0","summary":"加科思药业集团有限公司(股票代码:01167)于2026年3月23日公告称,公司当日于香港联交所场内回购普通股80,100股,占已发行股本约0.01019%。每股回购价介乎6.22港元至6.28港元,总金额为499,779港元。\n回购完成后,公司最新的已发行股本数量为786,039,480股,库藏股增至5,715,600股。公司回购授权于2025年6月10日通过,剩余可回购股份数量为78,873,528股。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。\n本公告由公司董事王晓洁签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620073579","title":"加科思-B(01167)3月20日斥资50.92万港元回购7.62万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620073579","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620073579?lang=zh_cn&edition=full","pubTime":"2026-03-20 20:29","pubTimestamp":1774009764,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)发布公告,于2026年3月20日,该公司斥资50.92万港元回购7.62万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416822.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181559439","title":"加科思-B:3月20日回购7.62万股股份,耗资约50.92万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1181559439","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181559439?lang=zh_cn&edition=full","pubTime":"2026-03-20 20:25","pubTimestamp":1774009557,"startTime":"0","endTime":"0","summary":"加科思药业集团有限公司于2026年3月20日发布公告,披露公司在香港联交所场内回购普通股,相关事项已于当日完成。本次回购股份数量共计76,200股,占公司现有已发行股本约0.00969%。每股价格介乎6.66港元至6.70港元,总耗资约50.92万港元。回购完成后,公司已发行股本合计791,755,080股,其中786,119,580股为流通股份,5,635,500股为库藏股。截至目前,公司已根据该项授权累计回购2,615,700股。公司进一步确认,本次行动已遵守香港联交所上市规则及相关法规的要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143185548","title":"加科思-B(01167)回购15万股股份,总额约101.3万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143185548","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143185548?lang=zh_cn&edition=full","pubTime":"2026-03-19 20:06","pubTimestamp":1773921969,"startTime":"0","endTime":"0","summary":"加科思-B于2026年3月19日发布翌日披露报表,宣布于当日回购股份并更新已发行股本情况。根据公告数据,公司当日回购15万股普通股,占当日前已发行股份约0.01908%,回购价格区间介乎每股6.72港元至6.78港元,合计支付约1,013,031港元。截至目前,公司已在交易所累计回购2,539,500股,占授权时已发行股本的0.32197%。公告同时确认上述股份回购行为符合香港联交所《上市规则》及相关法规的要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127136226","title":"加科思-B(01167)回购14.4万股股份,总额约99.8万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127136226","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127136226?lang=zh_cn&edition=full","pubTime":"2026-03-18 20:51","pubTimestamp":1773838315,"startTime":"0","endTime":"0","summary":"加科思药业集团有限公司(股票代码:01167)于2026年3月18日发布翌日披露报表,公告显示公司当日通过香港联交所场内回购144,000股股份,占回购前已发行股份总数约0.0183%。回购价介乎每股港币6.89元至7.01元,合计支付总额约港币998,043元。\n本次回购后,公司已发行股份(不包括库藏股)总数为786,345,780股,库藏股数为5,409,300股。根据公告,公司于2025年6月10日通过了股份回购授权,可回购股份总数为78,873,528股,而截至目前已在交易所累计回购2,389,500股。公司确认已遵守香港联交所相关上市规则及法例。本次公告由公司董事王晓洁签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620256365","title":"加科思-B(01167)3月18日斥资99.8万港元回购14.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620256365","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620256365?lang=zh_cn&edition=full","pubTime":"2026-03-18 20:51","pubTimestamp":1773838265,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)发布公告,于2026年3月18日斥资99.8万港元回购14.4万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415591.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176267587","title":"加科思-B(01167)回购144,000股股份,涉资约100.49万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176267587","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176267587?lang=zh_cn&edition=full","pubTime":"2026-03-17 17:56","pubTimestamp":1773741372,"startTime":"0","endTime":"0","summary":"加科思药业集团有限公司于2026年3月17日公告更新翌日披露报表,显示该公司当日回购144,000股普通股,占回购前已发行股份约0.0183%。每股购回价介乎每股6.92港元至7.02港元,合共付出价格1,004,886港元。回购完成后,已发行股份数量降至786,489,780股,库藏股增至5,265,300股,总已发行股本维持在791,755,080股。公司此前于2025年6月10日获得购回授权,可回购最多78,873,528股,截至目前已累计回购2,245,500股,占授权总数约0.2847%。公司在公告中确认,本次回购已遵守香港联交所证券上市规则等相关法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jacobiopharma.com","stockEarnings":[{"period":"1week","weight":0.1004},{"period":"1month","weight":0.1412},{"period":"3month","weight":0.0485},{"period":"6month","weight":0.0884},{"period":"1year","weight":1.3739},{"period":"ytd","weight":0.2559}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.0044},{"period":"3month","weight":-0.0363},{"period":"6month","weight":0.0277},{"period":"1year","weight":0.2087},{"period":"ytd","weight":0.0124}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"加科思药业集团有限公司是一家主要从事临床阶段新药研发的投资控股公司。该公司主要负责创新肿瘤疗法的自主发现和开发。该公司主要药物开发项目包括JAB-21822及JAB-3312临床阶段的变构SHP2抑制剂。该公司主要在中国市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.0037},{"month":2,"riseRate":0.5,"avgChangeRate":0.158834},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.004688},{"month":4,"riseRate":0.666667,"avgChangeRate":0.058575},{"month":5,"riseRate":0.4,"avgChangeRate":0.066021},{"month":6,"riseRate":0,"avgChangeRate":-0.081428},{"month":7,"riseRate":0.4,"avgChangeRate":0.073857},{"month":8,"riseRate":0.2,"avgChangeRate":0.005746},{"month":9,"riseRate":0.6,"avgChangeRate":-0.002238},{"month":10,"riseRate":0.2,"avgChangeRate":-0.065405},{"month":11,"riseRate":0.4,"avgChangeRate":0.020921},{"month":12,"riseRate":0.2,"avgChangeRate":-0.06824}],"exchange":"SEHK","name":"加科思-B","nameEN":"JACOBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.41.0","shortVersion":"4.41.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"加科思-B(01167)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供加科思-B(01167)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"加科思-B,01167,加科思-B股票,加科思-B股票老虎,加科思-B股票老虎国际,加科思-B行情,加科思-B股票行情,加科思-B股价,加科思-B股市,加科思-B股票价格,加科思-B股票交易,加科思-B股票购买,加科思-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"加科思-B(01167)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供加科思-B(01167)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}